Background {#Sec1}
==========

The hallmarks of cancer, which categorises the survival and proliferative mechanisms of cancer cells, was first described by Hanahan and Weinberg \[[@CR1]\]. Although these aspects of cancer are well studied, and even with the advances in personalized medicine for patient tailored treatment, there still exists cancer forms for which limited treatment options are available. Breast cancer, the most prevalent cancer in women globally, has an estimated 1.67 million cases diagnosed in 2012 \[[@CR2]\]. Women of Arab \[[@CR3]\] and African descent \[[@CR4]\] present breast cancer at an earlier age, have more aggressive tumour types with a high prevalence of triple negative breast cancer. Penta-negative tumours (i.e., negative for the estrogen and progesterone receptors, EGFR, HER2, and cytokeratin 5/6) have also been reported in Saudi women \[[@CR5]\]. In our previous seminal investigations \[[@CR6], [@CR7]\], we reported the anticancer potential of extracts obtained from brine-pool microbes. Most of these extracts were active against estrogen receptor positive (ER+) breast cancer cells. Since the triple-negative type of breast cancer is a more aggressive form and as currently no therapies are available, we aimed to identify new sources of anticancer compounds that can pave the way to develop novel therapies for triple negative breast cancer.

Approximately 60 % of current anticancer therapeutics are derived from natural products, including, for example, marine-derived compounds such as cytarabine, trabectedin, eribulin, and dolastatins \[[@CR8]\]. A review by Agrawal et al. \[[@CR9]\] described nonribosomal peptides isolated from marine microbes having anticancer activity while in a research article Neelam et al. \[[@CR10]\] discovered a marine halo-alkaliphilic bacteria species possessing anti breast cancer activity. This evidence supports the pursuit of mining marine environments for the discovery of new anticancer agents. Twenty-five (mostly) anaerobic deep-sea brine pools with extremely high salt concentrations have been reported in the Red Sea. Multi-extremophilic microbes that inhabit these environments are not only adapted to high salinity (4--26%), but also to elevated temperature, low oxygen concentrations, and high concentrations of heavy metals \[[@CR11]--[@CR14]\]. These extreme marine environmental conditions favour the production of secondary metabolites and thus potentially unique and potent natural compounds. Extremophilic marine bacterial species from these environments, therefore, present a unique opportunity for discovering novel anticancer compounds \[[@CR6], [@CR7]\] that address the ever-changing need for improved chemotherapeutic drugs.

This study reports on anticancer activity of extracts from bacterial isolates from different habitats around brine pools within the Red Sea. We screened a total of 60 extracts against seven cell lines representing colorectal carcinoma, fibrosarcoma, breast carcinoma, cervical carcinoma, neuroblastoma, and normal cell lines. After initial screening, active extracts (\> 30% growth inhibition) were selected for testing in selected cell lines to investigate if apoptotic activities were moderated by caspases (executors of apoptotic cell death).

Methods {#Sec2}
=======

Field sampling {#Sec3}
--------------

The inoculum for microbial isolations were collected during a cruise between Oct 16 and Nov 3 2011 as described in Sagar et al. \[[@CR7]\].

Source of bacterial isolates {#Sec4}
----------------------------

Sixty bacterial strains were isolated from different habitats in or around the brine pools (Table [1](#Tab1){ref-type="table"}). While the deep-sea brine pool habitats differ in their physicochemical characteristics \[[@CR15]\], several studies showed that all of these environments harbour high microbial diversity and biomass.Table 1Identification of microbial stains. Taxonomic identification based on 16S rRNA gene analysis and the source of inoculum for 60 microbial strainsNameSourceSalinity (w/v)Closest relativeSimilarity (16S rRNA genes)Accession no. of the strainsAccessionno. of the closest relativesSB9Discovery interface25%*Haloprofundus marisrubri*100%KJ999759FN594944SB3Discovery interface25%*Haloferax prahovense*97%KJ999758NR_028165SB29Discovery interface25%*Haloferax larsenii*98%KJ999757NR_028209SA10Kebrit brine26%*Haloferax prahovense*99%MG563761NR_028165ZGT108Erba interface10%*Ruegeria profundi*100%KP726355NR_029197ZGT114Erba interface10%*Microbulbifer salipaludis*98%KP726357NR_025232ZGT118Erba interface10%*Ruegeria marisrubri*100%KP726356NR_029197SJ5A-1Erba interface10%*Ponticoccus marisrubri*97%KP726358NR_044174SJ5BErba interface10%*Ponticoccus litoralis*99%MG764545NR_044174XI10Erba interface10%*Pseudoalteromonas mariniglutinosa*99%MG768922NR_028992H106Erba interface10%*Idiomarina zobellii*99%MG768917NR_0248921Kebrit brine26%*Halomonas axialensis*99%MG768918NR_0272192Kebrit interface20%*Halomonas salina*99%MG768925NR_0420503Kebrit interface20%*Marinimicrobium haloxylanilyticum*99%MG768919GQ9208394Kebrit interface20%*Halobacillus kuroshimensis*99%MG768920NR_0412625Erba interface10%*Chromohalobacter israelensis*99%MG768921NR_0254316Erba sediment18%*Alteromonas halophila*99%MG768928EU5837257Erba sediment18%*Halomonas taeanensis*98%MG768923NR_0430878Erba sediment18%*Halobacillus locisalis*99%MG768924NR_0257159Erba interface10%*Alteromonas macleodii*99%MG768926Y1822810Erba interface10%*Salinivibrio costicola.*99%MG768927NR_02870311Erba interface10%*Halomonas denitrificans*99%MG768930NR_04249112Erba interface10%*Pontibacillus marinus*99%MG768932NR_04301113Nereus interface10%*Pseudoalteromonas mariniglutinosa*98%MG768936NR_02899214Nereus interface10%*Pseudoalteromonas flavipulchra*99%MG768933NR_02512615Nereus interface10%*Salinivibrio sharmensis*99%MG768935AM27973416Nereus interface10%*Halomonas hamiltonii*100%MG768937AM94139617Nereus interface10%*Salinicola salarius*99%MG768934NR_04249018Discovery interface15%*Alteromonas macleodii*98%MG768957Y1822819Discovery interface15%*Halomonas halophila*99%MG768941NR_04269720Discovery interface15%*Alteromonas macleodii*97%MG768929AM88587021Discovery interface15%*Pontibacillus chungwhensis*98%MG768940NR_02581222Nereus interface10%*Salinicola salarius*98%MG768944NR_04249023Nereus interface10%*Zunongwangia profunda*99%MG768951NR_04398624Nereus interface10%*Marinobacter flavimaris*99%MG768954NR_02579925Nereus interface10%*Chromohalobacter marismortui*99%MG768956X8722226Kebrit interface20%*Salinivibrio proteolyticus*99%MG768958NR_04353627Nereus interface10%*Halomonas meridiana*99%MG768959AF21221728Erba sediment18%*Chromohalobacter israelensis*98%MG768971NR_02543129Erba sediment18%*Salinivibrio siamensis*99%MG770368NR_04155230Erba sediment18%*Idiomarina seosinensis*99%MG770369NR_02582631Erba sediment18%*Pseudoalteromonas carrageenovora*99%MG770359NR_02622032Erba sediment18%*Pseudoalteromonas ruthenica*99%MG770372NR_02514033Erba sediment18%*Idiomarina baltica*99%MG770373NR_02756034Erba interface10%*Pontibacillus halophilus*99%MG770364NR_04453235Erba interface10%*Alteromonas macleodii*99%MG770376Y1822837Nereus interface10%*Donghicolae burneus*99%MG770367NR_04392838Nereus interface10%*Halomonas aquamarina*99%MG770380NR_04206339Discovery interface15%*Idiomarina loihiensis*100%MG770382NR_02511940Discovery interface15%*Idiomarina zobellii*98%MG770370NR_02489241Nereus interface10%*Halomonas shengliensis*99%MG770371NR_04409942Nereus interface10%*Vibrio communis*99%MG770378GU07867343Nereus interface10%*Bacillus halodurans*99%MG770383NR_02544644Nereus interface10%*Vibrio natriegens*99%MG770400NR_02612445Nereus interface10%*Alteromonas macleodii*98%MG770410AM88587046Nereus interface10%*Thalassospira tepidiphila*100%MG770411NR_04149247Kebrit brine26%*Halostagnicola alkaliphila*99%MG775659AB53325653Nereus interface10%*Salegentibacter mishustinae*99%MG770459NR_02582054Nereus interface10%*Marinilactibacillus psychrotolerans*99%MG770461NR_02479455Erba interface10%*Alcanivorax dieselolei*99%MG773786NR_043106

PCR amplification {#Sec5}
-----------------

DNA extraction, PCR amplification, and bioinformatics analyses of 16S rRNA genes from biomass of bacterial strains was performed according to Sagar et al. \[[@CR7]\]. Sequences were deposited in Genbank, and accession numbers are listed in Table [1](#Tab1){ref-type="table"}.

Bacterial biomass {#Sec6}
-----------------

The inocula were streaked using three different media types as described by (Sagar et al. 2013 \[[@CR6], [@CR7]\]). These solidified media types were supplemented with either 10% or 15% or 20% or 26% NaCl (w/v) before autoclaving to mimic salt concentrations in their original habitat. All incubations were done in a Binder incubator (Type BD53, Binder, Tuttlingen, Germany). Strains reported here were isolated under oxic conditions (air, 21% O~2~) and atmospheric pressure (1 atm) described elsewhere \[[@CR16], [@CR17]\]. To collect biomass, all strains were grown for 2 to 3 weeks with constant agitation at 30 °C in 5.0 l of Marine Broth (Difco) supplemented with the respective concentration of NaCl. Bacterial biomass was harvested and ethyl acetate extracts were prepared according to Sagar et al. \[[@CR6], [@CR7]\].

Cell culturing {#Sec7}
--------------

BJ (Fibroblast), HCT (Colorectal adenocarcinoma), HT-1080 (Fibrosarcoma), MCF-7 (Breast Adenocarcinoma), IMR-32 (Neuroblastoma), BT20 (Breast Adenocarcinoma), and HeLa (Cervical carcinoma) were obtained from the American Type Cell Culture Collection (ATCC, Manassas, VA). The cells were cultured in DMEM (Dulbecco\'s Modified Eagle\'s Medium) containing 10% FCS (Foetal calf serum), and streptomycin (100 μg/mL) and penicillin (100 U/mL) in a 37 °C incubator supplying 5% CO~2~.

MTT assay {#Sec8}
---------

2.5 × 10^3^ cells were seeded per well in 384-well culture plates and treated with 200 μg/mL marine bacterial extracts for 48 h. Growth inhibitory effects of extracts were estimated by an MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay as previously described \[[@CR7]\]. A microtiter plate reader (BMG LabtechPHERAstar FS, Germany) was used to measure the OD (optical density) at 595 nm and the results were analyzed using Microsoft Office Excel©.

APOPercentage assay {#Sec9}
-------------------

Cells were seeded in quadruplicates in 96 well plates at a density of 5 × 10^3^ cells per well in 90 μL of media. After 24 h, 200 μg/mL extracts were added to the cells for 48 h with, while 30 min treatment with 10 mM H~2~O~2~ was used as a positive control. The cells were lifted and stained with the APOPercentage dye (Biocolor, UK), and analysed as described previously \[[@CR18]\].

Caspase-3/7 activity assay {#Sec10}
--------------------------

2.5 × 10^3^ cells were seeded in 20 μL of media in 384-well plates and allowed to settle overnight. Five microliters of extract (200 μg/mL) was added and further incubated for 48 h. Manufacturer's instructions were followed to estimate Caspase-3/7 activity by using ApoTox-Glo kit (Promega) and the luminescence was measured using BMG LabtechPHERAstar FS (Germany). The results were normalized to cell viability (measured using MTT assay).

Statistical analysis {#Sec11}
--------------------

The samples (untreated vs. treated) were compared by using Student's *t*-test and statistical significance was noted at *p* \< 0.05. A Z-score of ≥0.6 indicated robustness of assays \[[@CR15]\].

Results {#Sec12}
=======

Taxonomic classification of microbes isolated from the Red Sea {#Sec13}
--------------------------------------------------------------

Most bacteria isolated from the four brine pools Erba, Discovery, Kebrit, and Nereus were closely related to known and well described halophilic species within *Proteobacteria* and *Archaea* (Table [1](#Tab1){ref-type="table"}).

Anticancer activities of isolates in a panel of cell lines {#Sec14}
----------------------------------------------------------

A total of 60 extracts isolated from bacterial cultures from the four brine pools Erba, Discovery, Kebrait, and Nereus were screened for anticancer activity by determining cell growth inhibition through MTT assay (Table [2](#Tab2){ref-type="table"}). Extracts induced varying levels of growth inhibition and were classified into five groups - empty circle (\< 30%), quarter-moon (\> 30 and \< 40%), half-moon (\> 40 and \< 60%), three-quarter-moon (\> 60 and \< 80%) and full-moon (\> 80%). The skin fibroblast cell line BJ was used as a normal cell line control for screening anticancer activity of the extracts. BJ cell growth was inhibited by approximately 50% of extracts while the growth of neuroblastoma cell line IMR-32 remained largely insensitive to the treatment. Interestingly, the growth of the triple negative breast cancer cell line BT20 was sensitive to the majority of the extracts.Table 2The percentage growth inhibition of various cell lines after treatment with extracts. Growth inhibition of one normal (BJ) and six cancer cell lines treated with 200 μg/ml microbial ethyl-acetate extract for 48 h

Further analysis revealed that the majority of bacterial isolates inducing active growth inhibition (above 30%) in this study set were isolated from the Erba brine pool (Fig. [1](#Fig1){ref-type="fig"}). Figure [1](#Fig1){ref-type="fig"} represents the distribution of active bacterial extracts inducing greater than 30% growth inhibition found across the brine-pools.Fig. 1The percentage of active extracts from bacterial strains isolated from the respective brine-pools. Pie chart represents the distribution of extracts based on their source in the Red Sea that induced greater than 30% growth inhibition in various cancer cell lines at a concentration of 200 μg/ml after 24 h of treatment

Apoptosis as mode of anticancer activity {#Sec15}
----------------------------------------

We assessed phosphatidylserine exposure in cancer cells treated with selected microbial extracts using APOPercentage assay and monitored change in caspase-3/7 activity to determine if extracts induced apoptosis. For this purpose, the extracts inducing \> 30% growth inhibition were selected for apoptosis screening (Table [3](#Tab3){ref-type="table"}). Due to the availability of limited amount of microbial extracts, we performed apoptosis and caspase-3/7 activity assays only on extracts active in breast cancer, cervical cancer, and fibrosarcoma cell lines. Again, BJ cells were used as a control to identify extracts with selective anticancer activity. Extracts induced apoptosis in all cell lines. However four (ZGT118, XI10, 7 and 13), six (ZGT118, XI10, 13, 16, 30 and 55), one (9), and three (10, 15 and 22) extracts selectively induced apoptosis in MCF-7, BT20, HeLa and H T-1080 cells compared to BJ cells, respectively. The extract number 7 was only active against MCF-7 cells, whereas extracts 16 and 55 were selectively active against BT20 cells when the apoptosis-inducing potential of these extracts was compared among all five cell lines (Table [3](#Tab3){ref-type="table"}).Table 3The percentage apoptotic cell death induced by selected extracts in various cell lines. Heat map of extracts (200 μg/ml) inducing apoptosis in one normal (BJ) and selected cancer cell lines after 48 h treatment

A Caspase-3/7 activity assay was employed to gain insights into the type of apoptosis occurring, namely caspase-dependent or caspase-independent (Fig. [2](#Fig2){ref-type="fig"}a-d). The caspase-3/7 results showed a clear trend that a caspase-independent mechanism was mostly responsible for BJ cell death. Extract number 7 induced caspase-dependent apoptosis in MCF-7 cells but had no adverse effect on BJ cell death despite it inducing slight growth inhibition in BJ cells making it a promising drug candidate for future work. Extract number 19 induced caspase-dependent apoptosis in MCF-7, HeLa, and HT1080 cells but not in BJ cells, even though BJ cells stained positive for phosphatidylserine exposure by APOPercentage assay (Table [3](#Tab3){ref-type="table"}). Caspase-3/7 activity increased in BT20 cells compared to BJ cells in response to extracts ZGT108, ZGT114, 12, 24, 37, 54 and 55. HeLa cells and HT1080 cells displayed significantly increased caspase-3/7 activation in response to extracts 4 and 19, respectively (Fig. [2](#Fig2){ref-type="fig"}). Interestingly, extract number 55 showed selectivity towards BT20 cells by inhibiting its growth and inducing apoptosis via caspase-3/7, neither of which was observed for BJ cells.Fig. 2Caspase 3/7 Activity in cells treated with bacterial extract. Normal skin fibroblast cell line BJ and four cancer cell lines MCF-7, BT20, HeLa and HT1080 were treated with 200 μg/ml bacterial extract for 48 h (**a**-**d**). Fold change in Caspase-3/7 activity relative to untreated was determined as per manufacturer's instructions and students t-test was used to determine significance where \* indicates *p* \< 0.05

Discussion {#Sec16}
==========

As a follow-up from our previous studies \[[@CR6], [@CR7]\], we screened extracts from 60 marine bacteria isolated from brine pools of the Red Sea. We would like to emphasize that in our previous two investigations, we could only find extracts active against MCF-7 (ER+) cells, but the current study reports anticancer activities of the extracts isolated from the Red Sea brine-pool harboring bacteria against fibrosarcoma, cervical cancer and particularly BT20 (triple negative) cancer cells. Primary cytotoxicity screening of all extracts against seven cell lines representing five different cancers enabled us to broadly identify potential anticancer extracts from deep-sea microbes. All extracts were also screened against one normal fibroblast cell line (BJ) to further identify those who exhibited selectivity for cancer, but not normal cells.

We investigated whether the brine-pool location had any correlation with anticancer activity induced by the bacterial isolates. Of all isolates from the respective brine-pools, we found that about 50% of all isolates collected from Erba Deep (located at a depth of 2395 m), showed greater than 30% growth inhibition (Fig. [1](#Fig1){ref-type="fig"}). The most closely related validly described species to these strains are (Table [1](#Tab1){ref-type="table"}): *Chromohalobacter israelensis, Salinivibrio siamensis, Idiomarina seosinensis, Pseudoalteromona scarrageenovora, Pontibacillus halophilus, and Alteromonas macleodii.* Our previous work \[[@CR7]\] has reported anticancer activity of *Chromohalobacter israelensis* in HeLa cells*.* A PubMed search did not reveal even a single article that describes the anticancer activity of any of the other five bacterial species. This highlights the fact that the microbes found in the deep-sea brine pools of the Red Sea (especially Erba Deep) may have unique anticancer compounds that can be explored in the future to develop new drugs.

Apoptosis assays (APOPercentage and caspase-3/7 activity) confirmed that several of these selected (showing \> 30% cell growth inhibition) extracts induced apoptotic cell death in cancer cell lines. This secondary screening process identified the extracts that selectively targeted a specific type of cancer via apoptotic cell death. We further investigated if extracts from a particular bacterial species have anticancer activity towards a specific cell line. Intriguingly, all three extracts (10, 15 and 22) that specifically inhibited the growth of fibrosarcoma cells (HT-1080) belonged to strains that were closely related to *Salinivibrio costicola, Salinivibrio sharmensis,* and *Salinicola salaries,* respectively, showing an enrichment of genus *Salinivibrio.* It would be interesting in future to investigate *Salinivibrio* extracts against other sarcomas as well. In MCF-7 cells, two out of four most active extracts (XI10 and 13) belonged to *Pseudoalteromonas mariniglutinosa.* This bacterial species had not been tested so far for anticancer activities (PubMed search). Secondary metabolites isolated from *Psuedoalteromonas* sp. off the coast of Brazil were reported to have potent anticancer activity against a leukemic and melanoma cell line, and the active compound, prodigiosin, was shown to be selective for cancers overexpressing ErbB-2 \[[@CR19]\]. In BT20 cells, extracts (16 and 55) showed selective cell death, and these extracts belong to species *Halomonas hamiltonii* and *Alcanivorax dieselolei*, respectively, none of which have ever been shown to have anticancer activity before. Our observation that *Halomonas* sp. and *Alteromonas* sp. contributed to the majority of growth inhibition may be attributed to their ability to produce molecules including exopolysaccharides (EPSs) and Dithiolopyrrolone (DTP), respectively. Exopolysaccharides (heterogeneous polymers) isolated from *Halomonas stenophila* and *Halomonas smyrnensis* induced pro-apoptotic effects against human T-leukemia cells \[[@CR20]\] and breast cancer MCF-7 cells \[[@CR21]\]. *Alteromonas* sp. are also well known for producing dithiolopyrrolone (DTP) molecules, which are known potent natural antibiotics; DTP obtained FDA approval as topical antibiotic Bactroban® (GlaxoSmithKline) \[[@CR22]\]. Not surprising, DTP also exhibits potent anticancer activity. These classes of antibiotic or polysaccharide type molecules most probably explain the anticancer activity we observed in this study.

In conclusion, our study has identified several microbial species that have the potential to kill selectively cancer cells, and interestingly many of these species have never been previously tested for their anticancer activities. Here, we provide seminal baseline data pinpointing which bacterial species and brine-pools should be targeted for future investigations to isolate anticancer compounds. This work is of particular importance for triple negative breast cancer therapeutic development as no drug exists till date that can effectively cure this aggressive form of breast cancer. Testing of these marine extracts against penta-negative breast cancer cells should be of great interest to future studies.
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